The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial
This study tested the effect of twice-daily intranasal oxytocin on cognitive outcomes in individuals with schizophrenia and schizoaffective disorder. We observed that intranasal oxytocin did not significantly improve cognition in individuals with schizophrenia compared to placebo.